CURI trades 82.5% below Wall Street's consensus target of $5.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CURI achieves its forward estimates and maintains a stable P/E multiple of 33.2x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, CuriosityStream Inc. (CURI) has a Wall Street consensus price target of $5.00, based on estimates from 9 covering analysts. With the stock currently trading at $2.74, this represents a potential upside of +82.5%. The company has a market capitalization of $162M.
Analyst price targets range from a low of $5.00 to a high of $5.00, representing a 0% spread in expectations. The median target of $5.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, CURI trades at a trailing P/E of -24.9x and forward P/E of 33.2x. Analysts expect EPS to grow +160.2% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
FUBOfuboTV Inc. | $290M | $9.85 | $39.00 | +295.9% | Hold | — | 15 |
AMCXAMC Networks Inc. | $439M | $9.99 | $8.50 | -14.9% | Hold | 5.4x | 41 |
CXDOCrexendo, Inc. | $255M | $7.87 | $11.50 | +46.1% | Buy | 18.7x | 6 |
NFLXNetflix, Inc. | $320.8B | $76.18 | $111.83 | +46.8% | Buy | 21.4x | 99 |
DISThe Walt Disney Company | $169.2B | $97.46 | $136.50 | +40.1% | Buy | 14.3x | 63 |
WBDWarner Bros. Discovery, Inc. | $65.5B | $26.12 | $30.83 | +18.0% | Hold | — | 32 |
FOXAFox Corporation | $24.1B | $54.92 | $70.67 | +28.7% | Buy | 10.9x | 48 |
ROKURoku, Inc. | $20.9B | $141.21 | $153.53 | +8.7% | Buy | 57.2x | 45 |
AMZNAmazon.com, Inc. | $2.6T | $245.98 | $307.77 | +25.1% | Buy | 27.9x | 94 |
AAPLApple Inc. | $4.6T | $310.66 | $327.00 | +5.3% | Buy | 35.5x | 111 |
Quick answers to the most common questions about buying CURI stock.
The consensus Wall Street price target for CURI is $5, representing 82.5% upside from the current price of $2.74. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CURI has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $5 implies 82.5% upside from current levels.
CURI trades at a forward P/E of 33.2121x, representing a moderate valuation. With analysts targeting $5 (82.5% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $5 for CURI, while the most conservative target is $5. The consensus of $5 represents the median expectation. These targets typically reflect 12-month expectations.
CURI is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 2 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CURI stock forecast based on 9 Wall Street analysts shows a consensus price target of $5, with estimates ranging from $5 (bear case) to $5 (bull case). The median consensus rating is "Buy".
CURI trades at a forward P/E ratio of 33.2x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CURI, with a "Buy" consensus rating and $5 price target (82.5% upside). 6 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CURI analyst price targets range from $5 to $5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $5 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.